Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

When immune thrombocytopenia purpura unveils congenital CMV infection: A case report

Breadcrumb

  • Home
  • When immune thrombocytopenia purpura unveils congenital CMV infection: A case report

Houda Guennouni Assimi 1, 2, *, Lina Seffar 1, 2, Houda Yacoubi 1, 2, Nezha Dini 3 and Abdelhamid Zrara 2

1 Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
2 Laboratory Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
3 Department of Pediatrics, Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health, Casablanca, Morocco.

World Journal of Biology Pharmacy and Health Sciences, 2026, 25(01), 266-269

Article DOI: 10.30574/wjbphs.2026.25.1.0039

DOI url: https://doi.org/10.30574/wjbphs.2026.25.1.0039

Received on 14 December 2025; revised on 20 January 2026; accepted on 22 January 2026

Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder characterized by immune-mediated platelet destruction and impaired thrombopoiesis. In infants, the occurrence of ITP requires a systematic search for secondary causes, particularly infectious etiologies. Cytomegalovirus (CMV), the most frequent cause of congenital viral infection worldwide, is known to induce profound immune dysregulation and hematopoietic abnormalities. We report the case of a three-month-old infant presenting with severe and relapsing ITP revealing a congenital CMV infection. Platelet recovery was achieved only after initiation of antiviral therapy. This case highlights the importance of an integrated immunological and biochemical diagnostic approach in infantile ITP and underscores the pathogenic role of CMV in immune-mediated thrombocytopenia.

Immune thrombocytopenia; Congenital cytomegalovirus infection; Infancy; Immune dysregulation; Megakaryopoiesis; Antiviral therapy

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0039.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Houda Guennouni Assimi, Lina Seffar, Houda Yacoubi, Nezha Dini, and Abdelhamid Zrara. When immune thrombocytopenia purpura unveils congenital CMV infection: A case report. World Journal of Biology Pharmacy and Health Sciences, 2026, 25(01), 266-269. Article DOI: https://doi.org/10.30574/wjbphs.2026.25.1.0039

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution